share_log

Lisata Therapeutics Analyst Ratings

Benzinga Analyst Ratings ·  Oct 19, 2022 07:03
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
10/19/2022 259.71% HC Wainwright & Co. $6 → $15 Maintains Buy

Lisata Therapeutics Questions & Answers

What is the target price for Lisata Therapeutics (LSTA)?

The latest price target for Lisata Therapeutics (NASDAQ: LSTA) was reported by HC Wainwright & Co. on October 19, 2022. The analyst firm set a price target for $15.00 expecting LSTA to rise to within 12 months (a possible 259.71% upside). 1 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Lisata Therapeutics (LSTA)?

The latest analyst rating for Lisata Therapeutics (NASDAQ: LSTA) was provided by HC Wainwright & Co., and Lisata Therapeutics maintained their buy rating.

When is the next analyst rating going to be posted or updated for Lisata Therapeutics (LSTA)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Lisata Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Lisata Therapeutics was filed on October 19, 2022 so you should expect the next rating to be made available sometime around October 19, 2023.

Is the Analyst Rating Lisata Therapeutics (LSTA) correct?

While ratings are subjective and will change, the latest Lisata Therapeutics (LSTA) rating was a maintained with a price target of $6.00 to $15.00. The current price Lisata Therapeutics (LSTA) is trading at is $4.17, which is out of the analyst's predicted range.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment